Clinical Trial Update: Autologous Adipose Derived MSCs Transplantation in Patient With Spinal Cord Injury. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating autologous adipose-derived mesenchymal stem cell transplantation in spinal cord injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Autologous adipose-derived mesenchymal stem cells (adipose-derived mesenchymal stem cells)

Snippet

Sponsor: R-Bio | Conditions: Spinal Cord Injury | Phase 1 | Status: COMPLETED